Transcenta Holding Limited (HKG:6628)
Hong Kong
· Delayed Price · Currency is HKD 1.620
+0.130 (8.72%)
May 30, 2025, 4:08 PM HKT
Transcenta Holding Market Cap
Transcenta Holding has a market cap or net worth of 657.46 million as of May 30, 2025. Its market cap has decreased by -13.94% in one year.
Market Cap
657.46M
Enterprise Value
743.85M
Revenue
11.98M
Ranking
n/a
PE Ratio
n/a
Stock Price
1.62
Market Cap Chart
Since April 27, 2022, Transcenta Holding's market cap has decreased from 2.75B to 657.46M, a decrease of -76.13%. That is a compound annual growth rate of -37.07%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 30, 2025 | 657.46M | 158.05% |
| Dec 31, 2024 | 254.77M | -82.96% |
| Dec 29, 2023 | 1.50B | 14.88% |
| Dec 30, 2022 | 1.30B | -52.74% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BeiGene | 229.25B |
| Hansoh Pharmaceutical Group Company | 154.89B |
| JD Health International | 132.48B |
| WuXi Biologics | 104.77B |
| Innovent Biologics | 102.44B |
| CSPC Pharmaceutical Group | 87.09B |
| Sino Biopharmaceutical | 79.09B |
| Akeso | 78.04B |